Factor XIa inhibitor versus DOAC in patients with AF at high stroke risk
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- ESC Congress 2024
Economic burden of CVD in 50 ESC member countries
Ramón Luengo-Fernandez, PhD
- ESC Congress 2024
Main messages of the 2024 ESC hypertension guidelines
Keith Churchwell, MD
- ESC Congress 2024
New ESC Guidelines for CCS and PAAD
Pierre Sabouret, MD, PhD
- ESC Congress 2024
Beneficial effects of MRAs in HF across the LVEF spectrum
Pardeep Jhund, MD, PhD